Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Tumori
|
February 7, 2006
[Cost effectiveness analysis of two adjuvant regimens in the treatment of colorectal cancer: an interpretation of the MOSAIC Study]
Barbara Rebesco, Elena Cantagalli, Maria Elvira Amalfitano
Global & Regional Health Technology Assessment
|
January 22, 2026
Claudio Jommi, Barbara Rebesco, Francesco Perrone, et al.
Healthcare (Basel, Switzerland)
|
November 27, 2021
Innovative Clinical-Organizational Model to Ensure Appropriateness and Quality in the Management of Medical Cannabis: An Italian Regional Case
Eleonora Russo, Clara Cannas, Maria Susanna Rivetti, et al.
Tumori
|
September 2, 2016
Risk management of onco-hematological drugs: how and how fast can we improve?
Mattia Altini, Marna Bernabini, Paolo Marchetti, et al.
Vaccines
|
June 27, 2025
Determinants of Accepting or Rejecting Influenza Vaccination-Results of a Survey Among Ligurian Pharmacy Visitors During the 2023/2024 Vaccination Campaign
Daniela Amicizia, Silvia Allegretti, Federico Grammatico, et al.
The Journal of Antimicrobial Chemotherapy
|
July 23, 2009
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Matteo Bassetti, Filippo Ansaldi, Laura Nicolini, et al.
Plos One
|
May 9, 2015
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes
Patrizia Fabbi, Paolo Spallarossa, Silvano Garibaldi, et al.
Frontiers in Immunology
|
June 19, 2018
Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
Delfina Costa, Roberta Venè, Roberto Benelli, et al.
American Journal of Hematology
|
April 17, 2016
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients
Fabio Guolo, Paola Minetto, Marino Clavio, et al.
Journal of Clinical Medicine
|
October 23, 2021
Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region
Antonio Vena, Giovanni Cenderello, Elisa Balletto, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Tumori
|
February 7, 2006
[Cost effectiveness analysis of two adjuvant regimens in the treatment of colorectal cancer: an interpretation of the MOSAIC Study]
Barbara Rebesco, Elena Cantagalli, Maria Elvira Amalfitano
Global & Regional Health Technology Assessment
|
January 22, 2026
Claudio Jommi, Barbara Rebesco, Francesco Perrone, et al.
Healthcare (Basel, Switzerland)
|
November 27, 2021
Innovative Clinical-Organizational Model to Ensure Appropriateness and Quality in the Management of Medical Cannabis: An Italian Regional Case
Eleonora Russo, Clara Cannas, Maria Susanna Rivetti, et al.
Tumori
|
September 2, 2016
Risk management of onco-hematological drugs: how and how fast can we improve?
Mattia Altini, Marna Bernabini, Paolo Marchetti, et al.
Vaccines
|
June 27, 2025
Determinants of Accepting or Rejecting Influenza Vaccination-Results of a Survey Among Ligurian Pharmacy Visitors During the 2023/2024 Vaccination Campaign
Daniela Amicizia, Silvia Allegretti, Federico Grammatico, et al.
The Journal of Antimicrobial Chemotherapy
|
July 23, 2009
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Matteo Bassetti, Filippo Ansaldi, Laura Nicolini, et al.
Plos One
|
May 9, 2015
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes
Patrizia Fabbi, Paolo Spallarossa, Silvano Garibaldi, et al.
Frontiers in Immunology
|
June 19, 2018
Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
Delfina Costa, Roberta Venè, Roberto Benelli, et al.
American Journal of Hematology
|
April 17, 2016
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients
Fabio Guolo, Paola Minetto, Marino Clavio, et al.
Journal of Clinical Medicine
|
October 23, 2021
Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region
Antonio Vena, Giovanni Cenderello, Elisa Balletto, et al.
Page
of 1